Nuvaira has developed the Nuvaira Lung Denervation System to treat patients with chronic obstructive pulmonary disease (COPD) refractory to drug therapy.
Location: United States, Minnesota, Minneapolis
Total raised: $79M
Investors 2
| Date | Name | Website |
| - | US Venture... | usvp.com |
| - | Lightstone... | lightstone... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.02.2019 | - | $79M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 11.08.2021 | Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone US... | prnewswire... | |
| 23.11.2020 | Nuvaira Announces Published Two-Year Results in COPD Patient... | prnewswire... | |
| 21.07.2020 | Seattle-area medical device startup CurvaFix raises $10.7M f... | Medical device startup CurvaFix raised $10.7 million to spur development of its technology that help... | geekwire.c... |
| 13.02.2019 | Minneapolis-Based Nuvaira Raises $79 Million To Fight Chroni... | Nuvaira, a Minneapolis, Minnesota-based developer of novel therapeutic medical devices for treating ... | pulse2.com... |
| 13.02.2019 | Term Sheet — Wednesday, February 13 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content Securing the enterprise without... | fortune.co... |
| 12.02.2019 | Daily funding roundup - February 12th, 2019 | Zoovu $14M; Chainalysis raised $16M; Second Measure raised $20M; Nuvaira raised $79M iFarm Project: ... | vator.tv/n... |
| 12.02.2019 | Nuvaira Announces a $79M Financing | MINNEAPOLIS, MN, Nuvaira, a developer of novel therapeutic medical devices to treat obstructive lu... | vcnewsdail... |
| 11.02.2019 | Nuvaira Announces a $79 Million Financing Round to Pursue Gr... | - | usvp.com/n... |
| 11.02.2019 | Nuvaira raises $79M for lung nerve ablation procedure for CO... | Nuvaira has raised $79 million in equity financing to continue late-stage clinical development of it... | fiercebiot... |
| 11.02.2019 | Nuvaira Announces a $79 Million Financing Round to Pursue Gr... | - | lightstone... |
Show more